LISTEN: A genome-editing first, Trump on Wall Street, and biotech red flags
Can genome-editing work in actual people? Are CEOs oversharing? And how do you sniff out a bad bet before it happens? Find out on the latest episode of our podcast,…
by Damian Garde and Rebecca Robbins
Aug 23, 2018
1 minute
Can genome-editing work in actual people? Are CEOs oversharing? And how do you sniff out a bad bet before it happens?
You’re reading a preview, subscribe to read more.
Start your free 30 days